Summary Antineoplastic drugs, given in the perioperative period, are thought to be a hazard to wound repair. Since fibroblast collagen synthesis is crucial to healing, we examined the effects of bleomycin, cisplatin and 5-fluorouracil on collagen synthesis in confluent cultures of fibroblasts from human colon and skin. The drugs were added in final concentrations between 0.1 and 501M.
lower concentrations than those needed to suppress non-stimulated synthesis. This effect was not observed in fibroblasts from colon.
The possible implications of these observations, as pertain to the use of perioperative chemotherapy, are discussed. Since 5-fluorouracil did not directly affect collagen synthesis in colon fibroblasts under any of the conditions tested it is suggested that the data support the contention that this drug is relatively harmless for intestinal healing.
At present, surgery remains the only effective treatment modality for patients with malignant gastro-intestinal tumours. However, the occurrence of local and/or regional recurrences constitutes a major problem in the management of such patients. Recurrence rates may be reduced by antineoplastic therapy. Adjuvant treatment for colorectal cancer continues to centre on the use of 5-fluorouracil and regimens that include 5-fluorouracil offer the greatest hope for patients with this malignancy (Grem, 1991) . It can be argued that the most suitable time for such therapy would be during or immediately after tumour-reducing surgery (Harris & Mastrangelo, 1991) . Since it is generally accepted that most antineoplastic agents used in the perioperative period will impede tissue repair (Falcone & Nappi, 1984) , the healing of intestinal anastomoses appears to be at risk after administration of this class of compounds (Koruda & Rolandelli, 1990) . Indeed, studies from our laboratory have shown that a combination of bleomycin, cisplatin and 5-fluorouracil, given once a day over 5 consecutive days, severely impairs the development of strength in experimental intestinal anastomoses constructed on the third day of the cytostatic regimen (de Roy van Zuidewijn et al., 1986 van Zuidewijn et al., , 1991 . In contrast, administration of 5-fluorouracil alone appears to be less detrimental (Hillan et al., 1988; de Waard et al., manuscript in preparation) .
The strength of the intact and the anastomosed bowel wall is derived from collagen fibrils. Normal anastomotic healing is characterized by a strongly enhanced collagen synthetic activity (Jiborn et al., 1980; Martens & Hendriks, 1991) . The loss of strength encountered after administration of the cytostatics mixture mentioned above is attended by diminished deposition of collagen in the wound area as a result of a massive inhibition of the collagen synthetic capacity (Martens et al., 1992a) . Fibroblasts are the major source of newlyformed collagen in a healing wound. Thus, inhibition of wound collagen synthesis by antineoplastic agents may be the result of their effects on fibroblasts chemotaxis and proliferation, either direct or indirect through effects on macrophages, which cells play a pivotal regulatory role in the healing sequence (Fukasawa et al., 1990) . This way, the diminished protein synthesis would simply be the result of a reduced presence of fibroblasts in the wound area. In addition, these drugs may directly affect fibroblast protein synthesis. Very few studies are known which report on the specific effects of antineoplastic agents on fibroblast collagen synthesis. We have examined if, and to what extent, bleomycin, cisplatin and 5-fluorouracil inhibit fibroblast collagen synthesis and if these effects are specific for collagen. For this purpose, we have used fibroblasts from both human colon and skin since we found recently that collagen production in these cells may react differently to various stimuli (Martens et al., in press) .
We also investigated the effects of the three antineoplastic agents on fibroblast collagen synthesis measured after addition of transforming growth factor P (TGF1). TGFP enhances fibroblast collagen production (Ignotz & Massague, 1986) and, if applied topically, promotes wound healing (Jones et al., 1991) . Its intrinsic role in the repair process is indicated by its transient and localised expression in healing wounds (Cromack et al., 1987; Kane et al., 1991) . Therefore, interference with TGF1-induced fibroblast collagen synthesis may seriously affect wound repair.
Materials and methods

Materials
All supplies for cell culture were purchased from Life Technologies (Breda, The Netherlands). The cytostatics used were bleomycin (Lundbeck, Amsterdam, The Netherlands), cisplatin (Lederle, Etten-Leur, The Netherlands) and 5-fluorouracil (PBS) . Twenty-four hours later the medium was replaced by the same medium plus ascorbic acid (50 ytg ml-'), P-aminopropionitrile (50 Ag ml-') and 2 1iCi ml-' [2,3-3H]proline for the final 24 h of culture. The antineoplastic agents and TGFP were added during the labelling period.
After the labelling period the cells and medium were scraped from the wells and the wells were washed twice with 1 ml of 50 mM Tris-HCl pH 7.6 containing 25 mM ethylenediaminetetraacetic acid (EDTA), 10 mM N-ethylmaleimide (NEM), 1 mM phenylmethylsulfonylfluoride (PMSF) and 1 mM proline. The wash solution was added to the suspension which contained cells and medium. The final suspension was freeze/thawed three times and the proteins were precipitated with trichloroacetic acid (TCA; final concentration 10%). The radioactive protein was separated from free [3H]proline by repeated (3 x) washes with 5% TCA containing 1 mM proline at 4'C.
The final sediment was dissolved in 0.75 ml 0.2 M NaOH and neutralised by the addition of 0.3 ml I M HEPES and 0.3 ml 0.15 M HCI. Aliquots from this solution (0.1 ml) were counted to determine the incorporation in total protein. In order to determine proline incorporation into collagen 0.2 ml 50 mM Tris-HCl, pH 7.6, containing 100 mM CaC12 and 0.1 ml collagenase (chromatographically purified on a G200 gel filtration column) were added to a 0.5 ml aliquot of the solubilised sample and the mixture was incubated for 5 h at 37°C. The digestion was terminated by the addition of TCA and tannic acid up to final concentrations of 0.6 M and 3 mM, respectively. After centrifugation (O min; 14.500 g) a 1.0 ml aliquot of the supernatant was counted in a liquid scintillation analyser. The same procedure was followed without the addition of collagenase. Subtraction of the counts released in this blank incubation from those released in the presence of collagenase yielded the collagen specific incorporation (collagenase-digestible protein CDP), representing collagen synthesis. Subtraction of the radioactivity in the CDP fraction from that in total protein yields the incorporation into non-collagenous protein (NCP). Incorporation into CDP and NCP is quantified per well.
The relative collagen synthesis (RCS) was calculated with the formula (Peterkofsky et al., 1981) Figure 4 . Whilst cisplatin only inhibited basal collagen synthesis at concentrations higher than 10 DiM, TGF,B-induced collagen synthesis was already inhibited significantly at a concentration of 0.1 tLM. Likewise, fluorouracil was without effect on basal collagen synthesis but reduced TGFI3-induced collagen synthesis to basal levels from a concentration of 1 tiM upwards.
Discussion
The contention that antineoplastic agents, if given in the perioperative period, are a threat to uncomplicated wound (Cunliffe & Sugarbaker, 1989) . Therefore, research into the effects of the various antineoplastic agents on primary processes of the healing sequence is much needed in order to further assess their suitability for perioperative application.
Fibroblast collagen synthesis is crucial to the development of wound strength. Antineoplastic agents could interfere in this process in several ways. For instance, they could prevent the release of fibroblast-chemotactic mediators from platelets and macrophages (by suppressing the numbers of these cells) or inhibit fibroblast proliferation. In addition, they could interfere directly with fibroblast collagen synthesis. With regard to this last possibility, not much is known about the effect of drugs which are commonly used today, with the possible exception of adriamycin. The detrimental effects of this compound in experimental models are severe and undisputed: it lowers wound strength and collagen accumulation (Lawrence et al., 1986a) . Although it was shown recently that adriamycin induces decreased gene expression for type I collagen in skin wounds of rats (Salomon et al., 1990) , it has also been reported to reduce the synthesis of hydroxyproline in human skin fibroblasts by inhibiting prolyl hydroxylase activity (Sasaki et al., 1987) . No such equivocal data exist for 5-fluorouracil, which drug remains the cornerstone for chemotherapy of colorectal cancer (Grem, 1991) . While earlier reports shown impaired healing of experimental intestinal anastomoses (Goldman et al., 1969; Morris, 1979) , more recent data fail to support a detrimental effect (Hillan et al., 1988) . We have found that 5-fluororacil, administered intravenously or intraperitoneally once a day during the first 3 days after operation, did not affect strength or hydroxyproline content of intestinal anastomoses (de Waard et al., manuscript in preparation) .
Very recently Graf et al. (1992) reported decreased strength of experimental colonic anastomoses after 7 days of intraperitoneal administration of 5-fluorouracil. As with all experimental studies on the effects of antineoplastic agents on wound repair, results remain difficult to compare because variations in protocol, e.g. dose and mode and time of administration of the drug. 5-Fluorouracil is one of the few drugs that has been used clinically in the perioperative period: no evidence was found for increased anastomotic leakage after intravenous infusion commencing during or immediately after operation (Taylor et al., 1985; Klausner et al., 1986; Wolmark et al., 1990) . One clear result from the present experiments is that 5-fluorouracil does not directly affect collagen synthesis in colon fibroblasts, under any of the conditions tested. In addition, fibroblast proliferation appeared to be refractory to the presence of the drug. Inhibitory effects on proliferation of human fibroblasts have been reported after longer incubations with 5-fluorouracil (Wong et al., 1991) . Still, we believe that our results support the idea, which may be inferred from the clinical data available, that it should be safe to administer 5-fluorouracil immediately after resection of a colorectal cancer.
Cisplastin, which is often used together with 5-fluorouracil as adjuvant in the treatment of gastrointestinal tumours, is reported to impair the development of strength in rat intestinal anastomoses (Engelmann et al., 1983) . klthough no data on wound collagen content were supplied, our results show that cisplatin can strongly and, to a large extent, specifically suppress collagen synthetic capacity in colon fibroblasts. Thus, the evidence available cautions against the peri-operative use of cisplatin.
We have also tested the effects of bleomycin since this drug was included in the mixture administered in vivo in our previous experiments with rat intestinal anastomoses (de Roy van Zuidewijn et , 1991 Martens et al., 1992a) . No experiments have been reported on the effects of bleomycin alone on intestinal healing. Collagen synthesis in colon fibroblasts remains unaffected by bleomycin, in contrast to skin fibroblast where bleomycin induced a significant, though not very specific, inhibition. This appears in agreement with earlier results which show that bleomycin, at concentrations around I ylM, though increasing the amount of procollagen mRNA in the cell layer (Sterling et al., 1983) , eventually induces an inhibition of the synthesis of collagenous protein in the medium because it is being rapidly degraded intracellularly and extracellularly (Sterling et al., 1982) . It should be emphasised that the method employed in our experiments measures the net accumulation of collagen in cell layer plus medium, the bulk of the collagen being present in the medium.
The latter results illustrate the differences observed by us between colon and skin fibroblasts. Both absolute and relative collagen synthesis in colon fibroblasts remains unaffected by bleomycin while being inhibited in skin fibroblasts. Cisplatin strongly suppresses absolute and relative collagen synthesis in colon cells, while only affecting the absolute synthesis in skin fibroblasts at the highest concentration used. These results further extend our recent findings (Martens et al., in press ) that fibroblasts from both tissues exhibit divergent reactions to various stimuli and therefore may cause wounds in skin and intestine to behave differently under certain conditions. It is becoming increasingly clear that TGFPi plays an important regulatory role in wound healing (Cromack et al., 1987; Kane et al., 1991) . It has been shown that the expression of mRNA for TGF,B is decreased in adriamycin-impaired skin wounds (Salomon et al., 1990) and that exogenous TGFP reverses the adriamycin-induced inhibition of collagen accumulation in wound chambers (Lawrence et al., 1986b) . Therefore, it is interesting to observe that, if the collagen synthesis in skin fibroblast is stimulated by addition of TGF,B to the cultures, the additional activity is significantly inhibited by concentrations of antineoplastic agents which are much lower than those necessary to inhibit the basal synthetic activity. Possibly, this effect of antineoplastic agents on TGFI-elicited synthetic activity has far more direct implications for the process of wound healing than their effects on basal fibroblast activity. Further experiments are needed to elucidate the mechanism of this effect, e.g. regarding the question if it is mediated at the transcriptional or at the post-transcriptional level. The fact that TGFP-stimulated collagen synthesis in colon fibroblasts remains unaffected by 5-fluorouracil would then give additional weight to the argument that this drug is relatively harmless to colonic wound healing.
Altogether, the present data show that antineoplastic agents can have diverse effects on fibroblast collagen synthesis. If one wants to assess possible effects of a drug on tissue wound repair by measuring its effects on fibroblast collagen synthesis, it appears indicated to use fibroblasts derived from that particular tissue and to measure also after stimulation by TGFP . It should be emphasised that we do not propose (as yet) to use such an assay as a predictor of wound healing effects in vivo. Although we certainly believe the outcome to be pertinent to the repair sequence, at this time they can only be used to explain, and not to replace, observations made in vivo.
